Metacrine, Inc. (NASDAQ:MTCR) CEO Sells $22,374.00 in Stock

Metacrine, Inc. (NASDAQ:MTCR – Get Rating) CEO Preston Klassen sold 44,748 shares of the company’s stock in a transaction on Tuesday, April 19th. The stock was sold at an average price of $0.50, for a total value of $22,374.00. Following the completion of the sale, the chief executive officer now owns 922,510 shares of the […]

Related Keywords

United States , America , Preston Klassen , Morgan Stanley , Goldman Sachs Group Inc , Zacks Investment Research , America Corp , Nasdaq , Cim Investment Management Inc , Citadel Advisors , Metacrine Inc , Get Rating , Sachs Group , Cim Investment Management , Investment Management , Metacrine , Nasdaq Mtcr , Mtcr , Medical , Insider Trading , Nsider Trades , Stocks ,